serine has been researched along with 2,5-bis(5-hydroxymethyl-2-thienyl)furan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichwan, SJ; Ikeda, MA; Iseki, S; Ma, T; Ohtani, K; Otsu, M; Yamada, S | 1 |
Bu, Y; Cai, C; Cai, G; Cao, D; Cao, Y; Huang, C; Huang, D; Liao, DF; Shen, Y; Wang, Y; Zeng, X | 1 |
2 other study(ies) available for serine and 2,5-bis(5-hydroxymethyl-2-thienyl)furan
Article | Year |
---|---|
Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation.
Topics: Apoptosis; Caspase 3; Cell Line, Tumor; Furans; Genes, p53; Humans; Imidazoles; Phosphorylation; Piperazines; Poly(ADP-ribose) Polymerases; Serine; Transduction, Genetic; Tumor Suppressor Protein p53 | 2012 |
Targeting NF-κB RelA/p65 phosphorylation overcomes RITA resistance.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Furans; HCT116 Cells; HEK293 Cells; Humans; MCF-7 Cells; Mice, Nude; Multidrug Resistance-Associated Proteins; Mutation; Phosphorylation; RNA Interference; Serine; Signal Transduction; Time Factors; Transcription Factor RelA; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |